RCLFF yields 8.75% · JNJ yields 2.13%● Live data
📍 RCLFF pulled ahead of the other in Year 1
Combined, RCLFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RCLFF + JNJ for your $10,000?
RCL Foods Limited, through its subsidiaries, engages in the food business in South Africa. It provides grocery products, pies, beverages, flour, milling products and specialty baking products, bakery products, buns and rolls, chicken products, sugar, pet food products, and molasses-based feed products, as well as mayonnaise, peanut butter, rusks, etc. It is also involved in grain-based feed and waste-to-value operations. The company sells its products primarily under the Ouma, Nola, Yum Yum, Nutso, Bobtail, Catmor, Dogmor, Ultra dog, Canine Cuisine, Optimizer, Feline Cusine, Mageu Number 1, Monati, Mnandi, Piemans, Supreme, Tafelberg, Safari, A1, 5 Star, Sunbake, Epol, Driehoek and Equus, and Selati brand names. RCL Foods Limited also provides sales, supply chain intelligence, warehousing, and distribution solutions. The company was formerly known as Rainbow Chicken Limited and changed its name to RCL Foods Limited in August 2013. The company was founded in 1960 and is based in Durban, South Africa. RCL Foods Limited is a subsidiary of Remgro Limited.
Full RCLFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.